Similarly, though 200 μg/mL ERRAC remarkably suppressed the cell migration (Figure 5C-D) and invasion (Figure 5E-F) of CRC cells, but simultaneous treatment with overexpression of LDB2 could remarkably promote the migration and invasion ability compared with group 200 μg/mL ERRAC only (Figure 5C-F). Here, LDB2 is linked to colorectal carcinoma.